Koers American BriVision (Holding) Corporation OTC Markets
Aandelen
ABVC
US0247332069
Biotechnologie & Medisch Onderzoek
Omzet 2022 | 0,97 0,9 | Omzet 2023 | 0,15 0,14 | Marktkapitalisatie | 8,95 mln. 8,27 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -16 mln. -14,79 mln. | Nettowinst (verlies) 2023 | -10 mln. -9,24 mln. | EV/omzet 2022 | 24.208.439 x |
Nettoschuld 2022 | 3,25 mln. 3,01 mln. | Nettoschuld 2023 | 2,31 mln. 2,14 mln. | EV/omzet 2023 | 73.880.417 x |
K/w-verhouding 2022 |
-1,2
x | K/w-verhouding 2023 |
-0,48
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 73,57% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | - | 23-06-23 | |
Leeds Chow
DFI | Director of Finance/CFO | 35 | 01-03-21 |
Eugene Jiang
CHM | Chairman | 38 | 01-07-15 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Yue Min Chung
BRD | Director/Board Member | 59 | 10-07-22 |
Shu Ling Chiang
BRD | Director/Board Member | 68 | - |
Eugene Jiang
CHM | Chairman | 38 | 01-07-15 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+15,58% | 121 mld. | |
+16,60% | 110 mld. | |
+18,08% | 25,98 mld. | |
-24,33% | 19,27 mld. | |
-19,35% | 15,99 mld. | |
-17,95% | 15,66 mld. | |
-48,32% | 14,5 mld. | |
+58,78% | 14,47 mld. | |
+4,91% | 13,91 mld. |